365 Cancer Prevention Society is a social service agency committed to serving the community through cancer prevention measures since 2003. It is a place where cancer fighters, caregivers and their loved ones can share personal stories, support one another, and be educated on how to prevent and cope with cancer.

Curie Oncology is a practice specialising in complex oncology care, focused on providing personalised, multi-disciplinary support for patients overcoming cancer. Committed to maximising each individual's chance of cure, the team utilises innovative molecular targeted treatments and harnesses the immune system, guided by precision diagnostics that reveal each cancer’s unique molecular drivers. Valuing every patient as family, Curie Oncology embraces advanced technology to ensure access to cutting-edge diagnostics and treatments. The practice also funds and conducts research to improve cancer care, working toward a future free from the fear of cancer.

In the last three decades, GESS has hosted Scientific Meetings (GIHep), Endoscopy Workshops and Postgraduate Courses for doctors and nurses annually. Its objectives are: To advance the knowledge and practice of Gastroenterology and Hepatology in Singapore. To promote research in Gastroenterology and Hepatology. To promote regional and international collaborations with other Gastroenterological societies. To organise meetings, seminars and conventions on Gastroenterology, Hepatology and Endoscopy. To publish educational materials in the field of Gastroenterology and Hepatology

The Hepatobiliary/Pancreatic Association in Singapore was established in response to the growing interest in hepatopancreatobiliary medicine. Initially proposed in 2008, the idea gained momentum when Singapore was invited to host the 2015 AP-HPBA meeting. Officially registered on August 3, 2012, the Association aims to set standards for managing HPB diseases, enhance patient care, and promote multidisciplinary collaboration among healthcare professionals. With a founding membership of 67, it emphasizes mentorship, training, and ethical research practices, fostering a community dedicated to advancing knowledge and treatment in this vital field.

HMI Group is a regional private healthcare provider operating in Singapore, Malaysia, and Indonesia. Established in 1994, it focuses on medical excellence and healthcare education through its network of hospitals, medical centers, and specialized clinics, including Mahkota Medical Centre, Regency Specialist Hospital, Eagle Eye Centre, and StarMed Specialist Centre. HMI aims to improve healthcare quality and accessibility across the region while driving innovation. Its mission is to enhance community health through human and technological advancements.

Innoquest Diagnostics Pte Ltd is a leading diagnostic laboratory formed from the merger of Quest Laboratories and Innovative Diagnostics. Established in 1995 and 1996, the company was officially launched in March 2021 after being acquired by Pathology Asia Holdings. Operating from seven state-of-the-art facilities in Singapore, Innoquest leverages advanced technology to perform over 10,000 tests daily. The company has played a vital role in Covid-19 testing, conducting over 2.1 million swab tests. Committed to transforming healthcare, Innoquest invites collaboration to innovate and improve the human condition.

The SGH Liver & Pancreas Support Group offers a vital community for patients with liver and pancreatic cancers, alongside their caregivers and medical teams. By focusing on both medical and emotional needs, the group fosters open conversations, helping patients rediscover themselves and stay motivated in their healing journey. Members share information and provide mutual support, ensuring that no one faces their chronic illness alone. Together, they work towards emotional and moral support, enhancing the overall healing experience and celebrating each other’s progress.

The National Foundation for Digestive Diseases (NFDD) is dedicated to advancing public understanding of the digestive system, including the gastrointestinal tract, liver, and pancreas. It focuses on the causes, diagnosis, prevention, and treatment of digestive diseases. Committed to supporting research on prevalent disorders in the region, NFDD collaborates with national and international organizations to enhance knowledge and resources. Additionally, it advocates for legislation to improve care for individuals affected by these conditions. Through fundraising and community engagement, NFDD aims to elevate awareness and promote effective treatment options for digestive health.

The National University Cancer Institute, Singapore (NCIS) is a premier public facility dedicated to treating both pediatric and adult cancers. As part of the National University Health System, NCIS focuses on personalized, comprehensive care encompassing cancer awareness, prevention, diagnosis, treatment, rehabilitation, and palliative care. Its mission revolves around four core areas: delivering quality patient care, advancing research from the lab to clinical treatments, training future healthcare professionals, and educating the public. By fostering collaboration among specialists—doctors, nurses, and researchers—NCIS aims to innovate cancer treatment while nurturing the next generation of medical leaders through partnerships with the Yong Loo Lin School of Medicine.

Parkway Cancer Centre (PCC) offers comprehensive cancer treatment in Singapore, delivered by a multidisciplinary team of specialists, nurses, and counselors. Using advanced medical technology, PCC provides holistic care in a supportive environment, focusing on patient well-being. They aim to ensure comfort and compassion, offering services that include medical oncology, surgery, radiation therapy, and palliative care. PCC's mission is to deliver premier, patient-centered cancer care while offering hope to those affected by cancer.

Raffles Medical Group is a prominent healthcare provider committed to enhancing health and well-being throughout the region. Their mission revolves around being a trusted partner in health, prioritizing compassionate care and professionalism. Raffles Medical offers a comprehensive range of medical services tailored to meet the diverse needs of patients. With a focus on excellence, they continually seek innovation to deliver exceptional value. By employing a team-based approach, Raffles Medical ensures that each patient receives the highest standard of care, with their well-being at the core of all they do.

The Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group, founded in 1997 by leading clinicians, focuses on advancing research and treatment for Hepatocellular Carcinoma (HCC). This collaboration conducts innovative preventive and therapeutic trials, uniting industry and academia to improve patient outcomes. With over 4,000 patients enrolled across 50 centers in 17 countries, the AHCC is committed to addressing the significant burden of HCC, especially in the Asia-Pacific region. Recognizing the urgent need for effective therapies, the group endeavors to enhance precision oncology and develop new strategies to combat this challenging disease.